Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by enriquesuave


V.TLT

RE:RE:RE:RE:Undertreated Patients.

I believe it was   At the time it was not disclosed what the...

May 31, 2021

V.TLT

RE:RE:Undertreated Patients.

Average bladder volume was used instead of maximum bladder volume.  Now...

May 31, 2021

V.TLT

RE:Dr McFarland discussing tlt and our drug

How was the presentation?  Was working could not listen. 

May 21, 2021

V.TLT

RE:RE:RE:Competitor results !

Exactly Instiladrin results were 24% not 50%. It's 50% of those who were...

May 20, 2021

V.TLT

Dr Sherri McFarland

https://twitter.com/BCCancerCenter/status/1394679031258300417/photo/1

May 19, 2021

V.TLT

RE:RE:Canadian COVID-19 Vaccine Development

I'm pretty sure Theralase will partner with a big Pharma for COVID...

May 12, 2021

V.TLT

RE:RE:RE:Insider

End of July is next Quarterly report, but if we get AGM in June this year...

May 4, 2021

V.TLT

RE:RE:RE:RE:Looking for help w/numbers for burn rate, cash on hand, et.

Nice points Cancer Slayer.  The N-803 + BCG combo trial is showing about...

April 30, 2021

V.TLT

RE:RE:Optimized Maintenance Study Treatment

  Only patients 5 & 6 got optimized treatment in PH1 and were CR for...

April 30, 2021

V.TLT

RE:Optimized Maintenance Study Treatment

I was under the impression that 4 of the 1st set of 12 were due to get a...

April 30, 2021

V.TLT

RE:RE:Chewing the fat. .5 .7 1. doses thoughts

Correct Float , 1st 12 patients received between 69% and 13% of the treatment...

April 28, 2021

V.TLT

RE:RE:Chewing the fat. .5 .7 1. doses thoughts

However when we get next data if 2 out of 3 or more from patients 16,17 and...

April 28, 2021

V.TLT

RE:Chewing the fat. .5 .7 1. doses thoughts

On average the 1st 12 patients of PH2 got undertreated by 75% and not 30% . &...

April 28, 2021

V.TLT

RE:RE:RE:RE:RE:RE:Tertiary objectives.

Now we can say that any and all treatments which require drug instillations...

April 28, 2021

V.TLT

RE:RE:RE:RE:Tertiary objectives.

What I wrote earlier seems to make sense. Patients 13 and on got an Optimized...

April 27, 2021

V.TLT

RE:RE:RE:wow, what a great day....

"In accordance with FDA guidelines to industry, the patients who have...

April 27, 2021

V.TLT

RE:RE:wow, what a great day....

For the next report, it would be good to see the 3 months data for all...

April 27, 2021

V.TLT

RE:wow, what a great day....

I don't know what the market expected, but we knew that we would only get...

April 27, 2021

V.TLT

RE:ALL IN ALL looks like a decent REPORT!

Yes results look good for patients treated with optimized procedure.  We...

April 27, 2021

V.TLT

RE:RE:RE:Tertiary objectives.

It seems possible that either 13 or 14 or 15 was the patient who died as this...

April 27, 2021